Application segmentation delineates the functional contexts in which Parathyroid Detectors are deployed, directly shaping market revenue streams. The dominant Surgical Guidance segment, accounting for roughly 55 % of total sales, encompasses intra‑operative localization during thyroidectomy and parathyroidectomy, where real‑time detection mitigates hypocalcemia risk and reduces operative time. The Diagnostic Imaging application, representing about 30 % of the market, includes pre‑operative localization using near‑infrared fluorescence or radio‑guided systems to map ectopic glands, thereby informing surgical planning and improving diagnostic accuracy. A smaller yet growing Research niche, estimated at 15 %, supports experimental protocols in endocrinology and device validation, driving innovation and future adoption. Collectively, these application categories constitute the core of the Parathyroid Detector market size, with each segment’s contribution reflected in procurement volume, pricing dynamics, and reimbursement pathways. This analytical breakdown underpins the broader Parathyroid Detector segmentation framework essential for strategic forecasting.